$NVS Cashflow Statement | Understand Stock

$NVS

$156.86 +$3.05 (1.98%) Close

$NVS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated cash flow statements

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Net income
Net income from continuing operations
Reversal of non-cash items and other adjustments
Dividends received from associated companies and others
Interest received
Interest paid
Other financial receipts
Other financial payments
Income taxes paid
Net cash flows from operating activities from continuing operations before working capital and provision changes
Payments out of provisions and other net cash movements in non-current liabilities
Changes in working capital and other operating cash flow items
Net cash flows from operating activities from continuing operations
Net cash flows from operating activities from discontinued operations
Total net cash flows from operating activities
Purchases of property, plant and equipment
Proceeds from sale of property, plant and equipment
Purchases of intangible assets
Proceeds from sale of intangible assets
Purchases of financial assets
Proceeds from sale of financial assets
Purchases of other non-current assets
Proceeds from sale of other non-current assets
Acquisitions and divestments of interests in associated companies, net
Acquisitions and divestments of businesses, net
Acquisitions of businesses
Acquisitions applying the optional concentration test
Divestments of businesses, net
Investments in time deposits and marketable securities
Proceeds from time deposits and from sale of marketable securities and commodities
Other investing cash flows, net
Net cash flows (used in)/(from) investing activities from continuing operations
Net cash flows used in investing activities from discontinued operations
Total net cash flows (used in)/from investing activities
Dividends paid to shareholders of Novartis AG
Purchases of treasury shares
Proceeds from exercised options and other treasury share transactions, net
Proceeds from non-current financial debts
Repayments of the current portion of non-current financial debts
Change in current financial debts
Repayments of other current financial debts
Payments of lease liabilities
Payments from changes in ownership interests in consolidated subsidiaries
Other financing cash flows, net
Net cash flows used in financing activities from continuing operations
Net cash flows from financing activities from discontinued operations
Total net cash flows used in financing activities
Net change in cash and cash equivalents before effect of exchange rate changes
Effect of exchange rate changes on cash and cash equivalents
Net change in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period

Comments